These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10761552)

  • 1. ['Medical technology assessment'; more than just efficacy].
    Buskens E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(13):622-6. PubMed ID: 10761552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic modeling in medical technology assessment. Fitting hearing aids in The Netherlands.
    Boas G; van der Stel H; Peters H; Joore M; Anteunis L
    Int J Technol Assess Health Care; 2001; 17(4):618-25. PubMed ID: 11758306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology assessment in medicine: methods, status and trends.
    Hendee WR
    Med Prog Technol; 1991; 17(2):69-75. PubMed ID: 1835752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health technology assessment and policy decisions on hyperbaric oxygen treatment.
    Mitton C; Hailey D
    Int J Technol Assess Health Care; 1999; 15(4):661-70. PubMed ID: 10645107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical technology assessment: economic evaluation of new technologies.
    Adang EM; Dirksen CD; Engel GL; Baeten CG
    Br J Hosp Med; 1995 Jun 7-20; 53(11):563-6. PubMed ID: 7655753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining quality health care with outcomes assessment while achieving economic value.
    Shaw LJ; Miller DD
    Top Health Inf Manage; 2000 Feb; 20(3):44-54. PubMed ID: 10747434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care technology: how can we tell if we can afford it? A Canadian viewpoint.
    Dolan A; Zingg W
    J Long Term Eff Med Implants; 1993; 3(4):277-82. PubMed ID: 10146729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The future of medical technology assessment in Germany--five proposals for its development].
    Berndt K; Hinzpeter B; Lauterbach KW
    Z Arztl Fortbild Qualitatssich; 1998 Aug; 92(6):401-5. PubMed ID: 9757520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incremental cost effectiveness of multifocal cataract surgery].
    Pagel N; Dick HB; Krummenauer F
    Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of research and value of development in early assessments of new medical technologies.
    Retèl VP; Grutters JP; van Harten WH; Joore MA
    Value Health; 2013; 16(5):720-8. PubMed ID: 23947964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of new medical technologies on health expenditures in Israel 2000-07.
    Rabinovich M; Wood F; Shemer J
    Int J Technol Assess Health Care; 2007; 23(4):443-8. PubMed ID: 17937832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indirect costs in health technology assessment].
    Jakubczyk M; Wrona W; Macioch T; Golicki D; Niewada M; Hermanowski T
    Pol Merkur Lekarski; 2010 Jan; 28(163):42-5. PubMed ID: 20369723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.